Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine

20252 citationsJournal Articlegold Open Access

Authors

Stevan G. Severtson · Office of Multidisciplinary Activities

Janis L. Breeze · Office of Multidisciplinary Activities

Manish K. Jha · Southwestern Medical Center

Abstract

Among patients with TRD treated with esketamine in real-world settings, significant improvements in depressive symptoms were observed over the six months following treatment initiation.

Topics & Keywords

Treatment of Major Depression Neurotransmitter Receptor Influence on Behavior Digital Mental Health Interventions

Publication Details

Published in: BMC Psychiatry

Volume 25, Issue 1, pp. 1195-1195

DOI: 10.1186/s12888-025-07485-w

Field-Weighted Citation Impact: 2.73

Command Palette

Real-world evaluation of change in depressive symptoms among patients with treatment-resistant depression treated with esketamine

Authors

Abstract

Topics & Keywords

Publication Details